Literature DB >> 19061488

First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report.

Magalie Menuet1, Fadi Bittar, Nathalie Stremler, Jean-Christophe Dubus, Jacques Sarles, Didier Raoult, Jean-Marc Rolain.   

Abstract

INTRODUCTION: Cystic fibrosis afflicted lungs support the growth of many bacteria rarely implicated in other cases of human infections. CASE
PRESENTATION: We report the isolation and identification, by 16S rRNA amplification and sequencing, of two emerging pathogens resistant to colistin, Brevundimonas diminuta and Ochrobactrum anthropi, in a 17-year-old woman with cystic fibrosis and pneumonia. The patient eventually responded well to a 2-week regime of imipenem and tobramycin.
CONCLUSION: Our results clearly re-emphasize the emergence of new colistin-resistant pathogens in patients with cystic fibrosis.

Entities:  

Year:  2008        PMID: 19061488      PMCID: PMC2628933          DOI: 10.1186/1752-1947-2-373

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  10 in total

1.  Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp.

Authors:  Corinne Teyssier; Hélène Marchandin; Hélène Jean-Pierre; Isabelle Diego; Hélène Darbas; Jean-Luc Jeannot; Anne Gouby; Estelle Jumas-Bilak
Journal:  J Med Microbiol       Date:  2005-10       Impact factor: 2.472

2.  16S ribosomal DNA amplification for phylogenetic study.

Authors:  W G Weisburg; S M Barns; D A Pelletier; D J Lane
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

3.  Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis.

Authors:  Nele Wellinghausen; Juliane Köthe; Beate Wirths; Anja Sigge; Sven Poppert
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 4.  Infective endocarditis and septic embolization with Ochrobactrum anthropi: case report and review of literature.

Authors:  M S Mahmood; A R Sarwari; M A Khan; Z Sophie; E Khan; S Sami
Journal:  J Infect       Date:  2000-05       Impact factor: 6.072

5.  Brevundimonas diminuta infections and its resistance to fluoroquinolones.

Authors:  Xiang Y Han; Roberto A Andrade
Journal:  J Antimicrob Chemother       Date:  2005-05-09       Impact factor: 5.790

6.  Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  D L Kiska; A Kerr; M C Jones; J A Caracciolo; B Eskridge; M Jordan; S Miller; D Hughes; N King; P H Gilligan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

Review 7.  Prosthetic mitral valve endocarditis due to Ochrobactrum anthropi: case report.

Authors:  M P Romero Gómez; A M Peinado Esteban; J A Sobrino Daza; J A Sáez Nieto; D Alvarez; P Peña García
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

Review 8.  Brevundimonas bacteremia: two case reports and literature review.

Authors:  Chih-Yu Chi; Chang-Phone Fung; Wing-Wai Wong; Cheng-Yi Liu
Journal:  Scand J Infect Dis       Date:  2004

Review 9.  Pelvic abscess due to Ochrobactrum intermedium [corrected] in an immunocompetent host: case report and review of the literature.

Authors:  Sagar A Vaidya; Diane M Citron; Marjorie B Fine; Georgette Murakami; Ellie J C Goldstein
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Inquilinus limosus and cystic fibrosis.

Authors:  Fadi Bittar; Anne Leydier; Emmanuelle Bosdure; Alexandre Toro; Martine Reynaud-Gaubert; Stéphanie Boniface; Nathalie Stremler; Jean-Christophe Dubus; Jacques Sarles; Didier Raoult; Jean-Marc Rolain
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

  10 in total
  14 in total

1.  Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.

Authors:  Chloé Dupont; Estelle Jumas-Bilak; Clara Doisy; Fabien Aujoulat; Raphaël Chiron; Hélène Marchandin
Journal:  Appl Environ Microbiol       Date:  2018-11-15       Impact factor: 4.792

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Whole-genome sequence of Chryseobacterium oranimense, a colistin-resistant bacterium isolated from a cystic fibrosis patient in France.

Authors:  Poonam Sharma; Sushim Kumar Gupta; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

4.  Evaluation of Exposure to Brevundimonas diminuta and Pseudomonas aeruginosa during Showering.

Authors:  Sandip Chattopadhyay; Sarah D Perkins; Matthew Shaw; Tonya L Nichols
Journal:  J Aerosol Sci       Date:  2017-12       Impact factor: 3.433

5.  Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000-2010.

Authors:  M R Lee; Y T Huang; C H Liao; T Y Chuang; C K Lin; S W Lee; C C Lai; C J Yu; P R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-03       Impact factor: 3.267

6.  First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate.

Authors:  Marisa N Almuzara; Claudia M Barberis; Carlos H Rodríguez; Angela M R Famiglietti; Maria S Ramirez; Carlos A Vay
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

7.  Translocation and dissemination of commensal bacteria in post-stroke infection.

Authors:  Dragana Stanley; Linda J Mason; Kate E Mackin; Yogitha N Srikhanta; Dena Lyras; Monica D Prakash; Kulmira Nurgali; Andres Venegas; Michael D Hill; Robert J Moore; Connie H Y Wong
Journal:  Nat Med       Date:  2016-10-03       Impact factor: 53.440

Review 8.  Bacterial Evasion of Host Antimicrobial Peptide Defenses.

Authors:  Jason N Cole; Victor Nizet
Journal:  Microbiol Spectr       Date:  2016-02

9.  Citizen-science based study of the oral microbiome in Cystic fibrosis and matched controls reveals major differences in diversity and abundance of bacterial and fungal species.

Authors:  Jesse R Willis; Ester Saus; Susana Iraola-Guzmán; Elena Cabello-Yeves; Ewa Ksiezopolska; Luca Cozzuto; Luis A Bejarano; Nuria Andreu-Somavilla; Miriam Alloza-Trabado; Andrea Blanco; Anna Puig-Sola; Elisabetta Broglio; Carlo Carolis; Julia Ponomarenko; Jochen Hecht; Toni Gabaldón
Journal:  J Oral Microbiol       Date:  2021-05-17       Impact factor: 5.474

Review 10.  Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings.

Authors:  Dinesh Sriramulu
Journal:  Microbiol Insights       Date:  2013-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.